Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05186597Unknown

Incidence of MIS-C and Other Complications Following SARS-CoV-2 Infection

Showing all 1 trials

Research Network

Active Sponsors

  • Copenhagen University Hospital, Rigshospitalet1
  • Innovation Fund Denmark1
  • Ministry of Education, Denmark1

Related Conditions

  • Covid19 Pandemic1
  • Sars Cov 2 Infection1
  • Multisystem Inflammatory Syndrome In Children1

Activity Timeline